Early triple antiviral therapy for COVID-19 - Authors' reply.

Hung, Ivan Fan-Ngai; Yuen, Kwok-Yung

Hung, Ivan Fan-Ngai; Yuen, Kwok-Yung.

Hung IF; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Yuen KY; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: kyyuen@hku.hk.

Lancet ; 396(10261): 1488, 2020 11 07.

Article in English | MEDLINE | ID: covidwho-915741

Subject(s)

Antiviral Agents; Coronavirus Infections; Pandemics; Pneumonia, Viral; Antiviral Agents/therapeutic use; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Humans; Interferon beta-1b/therapeutic use; Lopinavir; Ribavirin/therapeutic use; Ritonavir/therapeutic use; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections / Pandemics Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(20)32268-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google